Comparing 68Ga-CTR-FAPI and 18F-FDG PET/ CT in Cancer Detection

NCT06945432 | Completed

• 1 other identifier: YZhang
• Study Type: observational
• Target: 27
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to compare the diagnostic efficacy of 68Ga-CTR-FAPI PET/CT and 18F-FDG PET/CT in various malignant tumors

Conditions

Tumors; PET / CT; FDG PET/CT; FAPI

Outcome Measures

Primary Outcomes (1)

• Lesion uptake

  Standardized uptake value (SUV)

  1 day

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Malignant tumor patients diagnosed by histopathology and imaging

You may qualify if:

• (a) Age ≥ 18 years old; (b) Suspected or newly diagnosed malignant tumors, evaluating the therapeutic effect of the tumor, or discovering recurrence/metastasis; (c) Obtain approval from oncologists and agree to undergo 18F-FDG and 68Ga-CTR-FAPI PET/CT scans within one week.

You may not qualify if:

• (a) Pregnancy or lactation period; (b) Claustrophobia. (c) Serious health problems: such as severe heart, liver and kidney dysfunction, diseases that affect the metabolism or clearance of imaging agents.

Sponsors & Collaborators

• Lanzhou University Second Hospital: lead

Study Sites (1)

The Second Hospital of Lanzhou University

Lanzhou, Gansu, 730030, China

Location

MeSH Terms

Conditions

Neoplasms

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr.

Study Record Dates

• First Submitted: April 18, 2025
• First Posted: April 25, 2025
• Study Start: July 1, 2024
• Primary Completion: March 31, 2025
• Study Completion: April 5, 2025
• Last Updated: April 25, 2025

Record last verified: 2025-02

Locations

CN (1)